Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Excessive inflammation and failed resolution of the inflammatory response are underlying components of numerous conditions such as arthritis, cardiovascular disease, and cancer. Hence, therapeutics that dampen inflammation and enhance resolution are of considerable interest. In this study, we demons...
Main Authors: | Langer, Robert, Kamaly, Nazila, Fredman, Gabrielle, Subramanian, Manikandan, Gadde, Suresh, Pesic, Alexsandar, Cheung, Louis, Fayad, Zahi A., Tabas, Ira, Cameron Farokhzad, Omid |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2013
|
Online Access: | http://hdl.handle.net/1721.1/81300 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
by: Farokhzad, Omid C., et al.
Published: (2013) -
Nanomedicines for endothelial disorders
by: Toth, Michael J., et al.
Published: (2018) -
Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity.
by: Manikandan Subramanian, et al.
Published: (2015-01-01) -
Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles
by: Valencia, Pedro M, et al.
Published: (2015) -
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
by: Gabrielle Fredman, et al.
Published: (2016-09-01)